Trial Profile
IVIG for Acquired Immunodeficiency in Lung Transplant Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- 12 Feb 2019 Status changed from active, no longer recruiting to completed.
- 25 Jun 2009 New trial record